These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17976873)

  • 1. [Systemic sclerosis in men].
    Gaultier JB; Hot A; Cathébras P; Grange C; Ninet J; Rousset H
    Rev Med Interne; 2008 Mar; 29(3):181-6. PubMed ID: 17976873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Special features of systemic sclerosis in men].
    Ben Dhaou B; Derbali F; Aydi Z; Baili L; Boussema F; Ketari S; Kochbati S; Cherif O; Rokbani L
    Tunis Med; 2012; 90(8-9):641-5. PubMed ID: 22987380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.
    Pokeerbux MR; Giovannelli J; Dauchet L; Mouthon L; Agard C; Lega JC; Allanore Y; Jego P; Bienvenu B; Berthier S; Mekinian A; Hachulla E; Launay D
    Arthritis Res Ther; 2019 Apr; 21(1):86. PubMed ID: 30944015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is vasculopathy associated with systemic sclerosis more severe in men?
    Panopoulos ST; Bournia VK; Sfikakis PP
    J Rheumatol; 2013 Jan; 40(1):46-51. PubMed ID: 23118107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review.
    Freire M; Rivera A; Sopeña B; Tolosa Vilella C; Guillén-Del Castillo A; Colunga Argüelles D; Callejas Rubio JL; Rubio Rivas M; Trapiella Martínez L; Todolí Parra JA; Rodríguez Carballeira M; Iniesta Arandia N; García Hernández FJ; Egurbide Arberas MV; Sáez Comet L; Vargas Hitos JA; Ríos Blanco JJ; Marín Ballvé A; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Simeón Aznar CP;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):89-97. PubMed ID: 28980905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of male sex on survival in systemic sclerosis.
    Hussein H; Lee P; Chau C; Johnson SR
    J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M; Bonner A; Hudson M; Baron M; Pope JE;
    Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.
    Elhai M; Avouac J; Walker UA; Matucci-Cerinic M; Riemekasten G; Airò P; Hachulla E; Valentini G; Carreira PE; Cozzi F; Balbir Gurman A; Braun-Moscovici Y; Damjanov N; Ananieva LP; Scorza R; Jimenez S; Busquets J; Li M; Müller-Ladner U; Kahan A; Distler O; Allanore Y;
    Ann Rheum Dis; 2016 Jan; 75(1):163-9. PubMed ID: 25342760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort.
    Elhai M; Sritharan N; Boubaya M; Balbir-Gurman A; Siegert E; Hachulla E; de Vries-Bouwstra J; Riemekasten G; Distler JHW; Rosato E; Del Galdo F; Mendoza FA; Furst DE; de la Puente C; Hoffmann-Vold AM; Gabrielli A; Distler O; Bloch-Queyrat C; Allanore Y;
    Lancet Rheumatol; 2022 Nov; 4(11):e785-e794. PubMed ID: 38265945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002.
    Alamanos Y; Tsifetaki N; Voulgari PV; Siozos C; Tsamandouraki K; Alexiou GA; Drosos AA
    Semin Arthritis Rheum; 2005 Apr; 34(5):714-20. PubMed ID: 15846586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.
    Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH
    Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
    Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients].
    Vincent C; Agard C; Barbarot S; N'Guyen JM; Planchon B; Durant C; Pistorius MA; Dreno B; Ponge T; Stalder JF; Mercier JM; Hamidou M
    Rev Med Interne; 2009 Jan; 30(1):5-11. PubMed ID: 18757116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.